Western lifestyle with high salt consumption leads to hypertension and cardiovascular disease. High salt may additionally drive autoimmunity by inducing T helper (TH)17 cells, which may also contribute to hypertension. Induction of TH17 cells depends on the gut microbiota, yet the effect of salt on the gut microbiome is unknown. In mouse model systems, we show that high salt intake affects the gut microbiome, particularly by depleting Lactobacillus murinus. Consequently, L. murinus treatment prevents salt-induced aggravation of actively-induced experimental autoimmune encephalomyelitis and salt-sensitive hypertension, by modulating TH17 cells. In line with these findings, moderate high salt challenge in a pilot study in humans reduces intestinal survival of Lactobacillus spp. along with increased TH17 cells and blood pressure. Our results connect high salt intake to the gut-immune axis and highlight the gut microbiome as a potential therapeutic target to counteract salt-sensitive conditions.

No abstract

Wound healing capability is inextricably linked with diverse aspects of physical fitness ranging from recovery after minor injuries and surgery to diabetes and some types of cancer. Impact of the microbiome upon the mammalian wound healing process is poorly understood. We discover that supplementing the gut microbiome with lactic acid microbes in drinking water accelerates the wound-healing process to occur in half the time required for matched control animals. Further, we find that Lactobacillus reuteri enhances wound-healing properties through up-regulation of the neuropeptide hormone oxytocin, a factor integral in social bonding and reproduction, by a vagus nerve-mediated pathway. Bacteria-triggered oxytocin serves to activate host CD4+Foxp3+CD25+ immune T regulatory cells conveying transplantable wound healing capacity to naive Rag2-deficient animals. This study determined oxytocin to be a novel component of a multi-directional gut microbe-brain-immune axis, with wound-healing capability as a previously unrecognized output of this axis. We also provide experimental evidence to support long-standing medical traditions associating diet, social practices, and the immune system with efficient recovery after injury, sustained good health, and longevity.

Centenarians, or individuals who have lived more than a century, represent the ultimate model of successful longevity associated with decreased susceptibility to ageing-associated illness and chronic inflammation [1][2][3] . The gut microbiota is considered to be a critical determinant of human health and longevity [4][5][6][7][8] . Here we show that centenarians (average 107 yo) have a distinct gut microbiome enriched in microbes capable of generating unique secondary bile acids, including iso-, 3-oxo-, and isoallo-lithocholic acid (LCA), as compared to elderly (85-89 yo) and young (21-55 yo) controls. Among these bile acids, the biosynthetic pathway for isoalloLCA had not been described previously. By screening 68 bacterial isolates from a centenarian's faecal microbiota, we identified Parabacteroides merdae and Odoribacteraceae strains as effective producers of isoalloLCA. Furthermore, we generated and tested mutant strains of P. merdae to show that the enzymes 5a-reductase (5AR) and 3bhydroxysteroid dehydrogenase (3bHSDH) were responsible for isoalloLCA production. This secondary bile acid derivative exerted the most potent antimicrobial effects among the tested bile acid compounds against gram-positive (but not gram-negative) multidrug-resistant pathogens, including Clostridioides difficile and vancomycin-resistant Enterococcus faecium.These findings suggest that specific bile acid metabolism may be involved in reducing the risk of pathobiont infection, thereby potentially contributing to longevity. MainThe microbiome has long been recognized as a key player in determining the health status of ageing individuals through its role in controlling digestive functions, bone density, neuronal activity, immunity, and resistance to pathogen infection [9][10][11][12][13] . Microbial consortia in elderly individuals often show increased interindividual variability and reduced diversity, and are thus being linked to immunosenescence, chronic systemic inflammation, and frailty 6,14 . An integrated understanding of the dynamic balance and functions of microbial members with respect to ageing is essential for establishing a strategy toward rational manipulation of the microbiota for restoring and/or maintaining tissue homeostasis and overall health.Centenarians (aged 100 years and older) are known to be less susceptible to age-related diseases including hypertension, diabetes, obesity, and cancer 3,15 . Moreover, centenarians have likely survived periods of hunger and several bouts with infectious diseases such as influenza, tuberculosis, shigellosis, and salmonellosis 16 . It has been postulated that there are centenarian-specific members of the gut microbiota which, rather than representing a mere consequence of ageing, might actively contribute to maintaining homeostasis, resilience, and healthful ageing [4][5][6]8 . In this study, we aimed

The human body is colonized by microorganisms from all three domains of life, with the gastrointestinal tract exhibiting the greatest microbial density and diversity 1-3. Gut microorganisms outnumber the host by more than 25-fold in terms of genetic composition 4. Unsurprisingly, this vast microbial ecosystem interacts intimately and, for the most part, mutualistically with its human host, performing essential metabolic functions such as polysaccharide fermentation and vitamin biosynthesis that affect multiple aspects of host physiology, including maturation of the immune system 5. As such, perturbation of the homeostatic microbiota composition (known as dysbiosis 6,7) has been correlated with a myriad of diseases including inflammatory bowel disease (IBD) 8 , cancer 9 , autism 10 and metabolic conditions such as diabetes 11 , cardiovascular disease 12 and obesity 13-15 (reviewed extensively elsewhere 6,16,17). Culture-independent metagenomic approaches to characterize the microbiota, enabled by next-generation sequencing, have increased the sensitivity and power of such associative studies by enabling high-throughput analysis 18. However, although certain microbiota configurations are associated with disease, defining the composition of a healthy microbiota has proved difficult. Bacteroidetes and Firmicutes together account for the majority of gut commensals in healthy adults, but the relative abundance of species within these phyla, and even of the phyla themselves, varies greatly from person to person 19. Accordingly, the seminal Human Microbiome Project revealed that there is no core set of microbial taxa conserved across all people, precluding categorical classification of many commensal species as good or bad based on large-scale correlation analyses alone 2. In addition, while sequence-based microbiomewide association studies provide correlative support for the notion that commensals influence human health and disease, they address neither the causality nor the directionality of the host-microbiota relationship, as disease-associated dysbiosis could be a mere reflection of microbiota adaptation to pathophysiological host conditions. The recent shift towards causational studies has enabled the identification of bacterial species that directly contribute to host homeostasis in specific ways. In particular, the combination of two complementary reductionist approaches, that is, gnotobiotic and metabolite-based, has enabled a detailed mechanistic understanding of dysbiosis-mediated disease and microbiota-mediated immunomodulation 3,20-22 , in which specific bacterial species and their products play critical roles. Concurrently, advances in culture techniques along with high-resolution mass spectrometry have provided an additional lens through which to identify small molecules correlated with disease, setting the stage for more rigorous studies 23-25. The intestinal milieu is replete with small molecules produced by gut commensals, which can be either synthesized de novo or metabolized from dietary or host-deriv...

A recent epidemiological study showed that eating ‘fast food’ items such as potato chips increased likelihood of obesity, whereas eating yogurt prevented age-associated weight gain in humans. It was demonstrated previously in animal models of obesity that the immune system plays a critical role in this process. Here we examined human subjects and mouse models consuming Westernized ‘fast food’ diet, and found CD4+ T helper (Th)17-biased immunity and changes in microbial communities and abdominal fat with obesity after eating the Western chow. In striking contrast, eating probiotic yogurt together with Western chow inhibited age-associated weight gain. We went on to test whether a bacteria found in yogurt may serve to lessen fat pathology by using purified Lactobacillus reuteri ATCC 6475 in drinking water. Surprisingly, we discovered that oral L. reuteri therapy alone was sufficient to change the pro-inflammatory immune cell profile and prevent abdominal fat pathology and age-associated weight gain in mice regardless of their baseline diet. These beneficial microbe effects were transferable into naïve recipient animals by purified CD4+ T cells alone. Specifically, bacterial effects depended upon active immune tolerance by induction of Foxp3+ regulatory T cells (Treg) and interleukin (Il)-10, without significantly changing the gut microbial ecology or reducing ad libitum caloric intake. Our finding that microbial targeting restored CD4+ T cell balance and yielded significantly leaner animals regardless of their dietary ‘fast food’ indiscretions suggests population-based approaches for weight management and enhancing public health in industrialized societies.

The gut microbiome is a dynamic system that changes with host development, health, behavior, diet, and microbe-microbe interactions. Prior work on gut microbial time series has largely focused on autoregressive models (e.g. Lotka-Volterra). However, we show that most of the variance in microbial time series is non-autoregressive. In addition, we show how community state-clustering is flawed when it comes to characterizing within-host dynamics and that more continuous methods are required. Most organisms exhibited stable, mean-reverting behavior suggestive of fixed carrying capacities and abundant taxa were largely shared across individuals. This mean-reverting behavior allowed us to apply sparse vector autoregression (sVAR)—a multivariate method developed for econometrics—to model the autoregressive component of gut community dynamics. We find a strong phylogenetic signal in the non-autoregressive co-variance from our sVAR model residuals, which suggests niche filtering. We show how changes in diet are also non-autoregressive and that Operational Taxonomic Units strongly correlated with dietary variables have much less of an autoregressive component to their variance, which suggests that diet is a major driver of microbial dynamics. Autoregressive variance appears to be driven by multi-day recovery from frequent facultative anaerobe blooms, which may be driven by fluctuations in luminal redox. Overall, we identify two dynamic regimes within the human gut microbiota: one likely driven by external environmental fluctuations, and the other by internal processes.

Highlights d Thousands of gut bacterial genomes from worldwide human populations were sequenced d HGT occurs at high frequency in the gut microbiome of individual persons d HGT occurs more frequently in the microbiome of industrialized and urban populations d Transferred gene functions in the microbiome reflect the lifestyle of the host